Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Prummel

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Autoimmunity|May 16, 2006
A reduced IL2R (CD25) expression level in first and second degree female relatives of autoimmune thyroid disease patients. A sign of a poor capability to preserve tolerance?Thea G A Strieder, H A Drexhage, W K Lam-Tse, et al.
Clinical Endocrinology|April 12, 2001
Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatmentsC B Terwee, F W Dekker, M P Mourits, et al.
Clinical Endocrinology|August 6, 1999
Octreotide-scintigraphy is a disease-activity parameter in Graves' ophthalmopathyM N Gerding, F M van der Zant, E A van Royen, et al.
The British Journal of Ophthalmology|August 1, 1990
Extraocular muscle surgery for Graves' ophthalmopathy: does prior treatment influence surgical outcome?M P Mourits, L Koorneef, A M van Mourik-Noordenbos, et al.
Journal of Endocrinological Investigation|June 1, 1990
HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patientsR van der Gaag, W M Wiersinga, L Koornneef, et al.
European Journal of Endocrinology|July 27, 2006
A questionnaire survey on the management of Graves' orbitopathy in Europe, P Perros, L Baldeschi, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Autoimmunity|May 16, 2006
A reduced IL2R (CD25) expression level in first and second degree female relatives of autoimmune thyroid disease patients. A sign of a poor capability to preserve tolerance?Thea G A Strieder, H A Drexhage, W K Lam-Tse, et al.
Clinical Endocrinology|April 12, 2001
Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatmentsC B Terwee, F W Dekker, M P Mourits, et al.
Clinical Endocrinology|August 6, 1999
Octreotide-scintigraphy is a disease-activity parameter in Graves' ophthalmopathyM N Gerding, F M van der Zant, E A van Royen, et al.
The British Journal of Ophthalmology|August 1, 1990
Extraocular muscle surgery for Graves' ophthalmopathy: does prior treatment influence surgical outcome?M P Mourits, L Koorneef, A M van Mourik-Noordenbos, et al.
Journal of Endocrinological Investigation|June 1, 1990
HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patientsR van der Gaag, W M Wiersinga, L Koornneef, et al.
European Journal of Endocrinology|July 27, 2006
A questionnaire survey on the management of Graves' orbitopathy in Europe, P Perros, L Baldeschi, et al.
Pageof 7